BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Stereotaxis to Report First Quarter 2026 Financial Results on May 12, 2026

  April 21, 2026

   · 

  1 min read
• Press Releases

  Akari Therapeutics ASCO Abstract Acceptance Highlights Potential for AKTX-101 ADC to Treat KRAS Mutant Tumors

  April 21, 2026

   · 

  6 min read
• Press Releases

  NEXGEL New Strategic Partner, Sequence LifeScience™, Leads Financing with $5.5 Million to Complete Acquisition of Celularity Degenerative Disease Segment

  April 21, 2026

   · 

  5 min read
• Press Releases

  Brain Cancer Canada Marks Brain Cancer Awareness Month in May with National Landmark Lightings, Community Events, New Research Investments, and a Call to Action

  April 21, 2026

   · 

  4 min read
• Press Releases

  Forlong Biotechnology to Present Clinical Data from the First-in-human Study for FL115 (IL-15 Superagonist) in US Patients with Advanced Solid Tumors at 2026 ASCO Annual Meeting

  April 21, 2026

   · 

  2 min read
• Press Releases

  ImmunoScape Presents Data on Significant, Selective In-Vivo Expansion of Cell Therapy Product at AACR Annual Meeting

  April 21, 2026

   · 

  5 min read
• Press Releases

  Moderna Receives European Commission Marketing Authorization for mCOMBRIAX, Moderna’s mRNA Combination Vaccine Against Influenza and COVID-19

  April 21, 2026

   · 

  6 min read
• Press Releases

  Northwest Biotherapeutics Announces Establishment Of the Company’s Own Dedicated Leukapheresis Clinic

  April 21, 2026

   · 

  4 min read
• Press Releases

  Canadian Team Advances Breakthrough “Living” Cancer Diagnostic Platform Following National GAPP Funding

  April 21, 2026

   · 

  5 min read
• Press Releases

  ReviR Therapeutics Receives Strategic Investment from CureCMT to Advance a First-of-its-Kind Precision Medicine Platform for CMT

  April 21, 2026

   · 

  6 min read